Status:

COMPLETED

Treating Civilian Traumatic Brain Injury With High Definition Transcranial Direct Current Stimulation (ciTBI-HDtDCS)

Lead Sponsor:

The University of Texas at Dallas

Collaborating Sponsors:

National Institutes of Health (NIH)

National Institute on Deafness and Other Communication Disorders (NIDCD)

Conditions:

Traumatic Brain Injury

Word Finding Difficulty

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., pre-supplementary motor area) thought...

Detailed Description

Using two treatment arms, the study will examine improvement of verbal retrieval and other cognitive deficits associated with remote traumatic brain injury by comparing (1) 1 milliamp transcranial dir...

Eligibility Criteria

Inclusion

  • Participants are to be between the ages of 18-85, are non-military personnel and not veterans, and have had a traumatic brain injury (more than a year ago prior to study participation) that has led to a complaint of word finding difficulty since the brain injury, confirmed to represent a verbal retrieval deficit based on neuropsychological testing criteria. Traumatic brain injury must be in the mild to moderate range based on evaluation, including the Ohio State TBI Identification Method (administered by our research group). You must be fluent in speaking and reading English.

Exclusion

  • an implanted/electronic device, such as a pacemaker, metallic cranial or intracranial implant (e.g., ventriculoperitoneal shunt), or a neurostimulator (e.g., vagus nerve stimulator, spinal stimulator, deep brain stimulator, etc.).
  • skull defects
  • a history of a psychological or neurological disorder, including, dementia of any type, epilepsy or other seizure disorders, post-traumatic stress disorder, brain tumor, present drug abuse, stroke, blood vessel abnormalities in the brain, Parkinson's disease, Huntington's disease, or multiple sclerosis.
  • inability to give informed consent
  • currently pregnant
  • not a native English speaker

Key Trial Info

Start Date :

January 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 30 2024

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT05408975

Start Date

January 1 2023

End Date

November 30 2024

Last Update

February 21 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

The University of Texas at Dallas

Dallas, Texas, United States, 75235

2

University of Texas Southwestern Medical Center

Dallas, Texas, United States, 75390